The Vaccine Group Welcomes Two New Directors to its Board
The Vaccine Group (TVG) is pleased to announce the appointment of Neil Crabb and Professor Laura Bowater, MBE, to its
22 June 2026
The Vaccine Group (TVG) is pleased to announce the appointment of Neil Crabb and Professor Laura Bowater, MBE, to its
The Vaccine Group was pleased to see TVG CEO Dr Jeremy Salt contribute expertise to the recent STAR IDAZ International
The Vaccine Group’s bovine respiratory syncytial virus (BRSV) vaccine programme has been recognised in the 2025 Animal Research Breakthroughs Review published by
TVG is delighted to announce that a vaccine candidate to tackle Streptococcus suis (“S.suis”) in pigs developed with University of
The Vaccine Group (TVG) has demonstrated outstanding results in a cattle challenge trial conducted by the UK government’s Animal and
The Vaccine Group CEO, Dr Jeremy Salt, has been selected to sit on the Executive Committee of the Global African
Over the past 15 years African Swine Fever (ASF) has developed into an epidemic affecting pig producers globally. Until that
Jeremy Salt, TVG’s CEO talked with Proactive’s Stephen Gunnion about the company’s collaboration with global animal health firm Syva. Salt
